Research graph
References from Exceptionally Durable Response to First-Line S-1 Monotherapy in Metastatic Pancreatic Adenocarcinoma: A Case Report. Local targets link to admitted publications; unresolved targets remain external evidence.
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer
10.1056/nejmoa1011923 · 2011 · External reference
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
10.1056/nejmoa1304369 · 2013 · External reference
Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study
10.1200/jco.2012.43.3680 · 2013 · External reference
Resolution of liver metastases in response to S-1 monotherapy in advanced pancreatic cancer--a case report [Article in Japanese]
2006 · External reference
Chemotherapy-naïve advanced pancreatic cancer with multiple liver metastases successfully treated by S-1 monotherapy--a case report [Article in Japanese]
2006 · External reference
A case report of complete response to low-dose S-1 monotherapy for pancreatic cancer in elderly patient [Article in Japanese]
2012 · External reference
A case of pancreatic cancer with multiple liver metastases that developed postoperatively and showed a complete response with S-1 monotherapy [Article in Japanese]
2015 · External reference
Pathological complete response after S-1 therapy for an unresectable pancreatic head cancer with liver metastasis [Article in Japanese]
10.5833/jjgs.2016.0122 · 2017 · External reference
S-1 induced discoid lupus erythematosus-like lesions and long-term complete response for para-aortic lymph node recurrence of pancreatic ductal adenocarcinoma: a case report
10.1186/s40792-018-0460-1 · 2018 · External reference
Role of molecular imaging in prognosis, diagnosis, and treatment of gastrointestinal cancers: an update on new therapeutic methods
10.5662/wjm.v14.i4.93461 · 2024 · External reference
Diagnostic value of diffusion-weighted MRI for the detection of peritoneal and liver metastases in high-risk pancreatic ductal adenocarcinoma: a prospective pilot study
10.1245/s10434-025-17319-4 · 2025 · External reference
MRI analysis of relative tumor enhancement in liver metastases and correlation with immunohistochemical features
10.1186/s13244-024-01866-7 · 2024 · External reference
S-1 for the treatment of gastrointestinal cancer
10.1517/14656566.2012.709234 · 2012 · External reference
ESMO Clinical Practice Guideline Express Update on the management of metastatic pancreatic cancer
10.1016/j.esmoop.2025.104528 · 2025 · External reference
An oral fluoropyrimidine agent S-1 induced interstitial lung disease: a case report
10.5306/wjco.v2.i7.299 · 2011 · External reference
ESMO Clinical Practice Guideline Express Update on the management of metastatic pancreatic cancer
10.1016/j.esmoop.2025.104528 · ExternalCitation · doi-reference
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer
10.1056/nejmoa1011923 · ExternalCitation · doi-reference
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
10.1056/nejmoa1304369 · ExternalCitation · doi-reference
MRI analysis of relative tumor enhancement in liver metastases and correlation with immunohistochemical features
10.1186/s13244-024-01866-7 · ExternalCitation · doi-reference
S-1 induced discoid lupus erythematosus-like lesions and long-term complete response for para-aortic lymph node recurrence of pancreatic ductal adenocarcinoma: a case report
10.1186/s40792-018-0460-1 · ExternalCitation · doi-reference
Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study
10.1200/jco.2012.43.3680 · ExternalCitation · doi-reference
Diagnostic value of diffusion-weighted MRI for the detection of peritoneal and liver metastases in high-risk pancreatic ductal adenocarcinoma: a prospective pilot study
10.1245/s10434-025-17319-4 · ExternalCitation · doi-reference
S-1 for the treatment of gastrointestinal cancer
10.1517/14656566.2012.709234 · ExternalCitation · doi-reference
An oral fluoropyrimidine agent S-1 induced interstitial lung disease: a case report
10.5306/wjco.v2.i7.299 · ExternalCitation · doi-reference
Role of molecular imaging in prognosis, diagnosis, and treatment of gastrointestinal cancers: an update on new therapeutic methods
10.5662/wjm.v14.i4.93461 · ExternalCitation · doi-reference
Pathological complete response after S-1 therapy for an unresectable pancreatic head cancer with liver metastasis [Article in Japanese]
10.5833/jjgs.2016.0122 · ExternalCitation · doi-reference
